Day 2


Please find the session links next to their corresponding agenda item.

Thursday, April 28

11:00 AM 

FDLI Welcome and Announcements

Enter this session:

11:05 AM– 12:05 PM 

FDA’s COVID-19 Activities
Vanessa K. Burrows, Counsel, Simpson Thacher & Bartlett

Enter this session:

12:05 – 12:15 PM 


12:15 – 1:15 PM 

Regulation of Over-the-Counter (OTC) Drugs
Douglas B. Farquhar, Director, Hyman, Phelps & McNamara, PC

Enter this session:

1:15 – 1:25 PM


1:25 – 2:25 PM

Regulation of Drug Manufacturing
David L. Chesney, Principal and GM, DL Chesney Consulting, LLC

Enter this session:

2:25 – 2:35 PM


2:35 – 3:35 PM

Regulation of Drug Marketing
Alan G. Minsk, Partner, Arnall Golden Gregory LLP

Enter this session:

3:35 – 3:45 PM


3:45 – 5:00 PM

Violations and Enforcement
Frederick R. Ball, Partner, Duane Morris LLP, FDLI Board of Directors

Enter this session:

5:00 PM


An access link will be provided to attendees via email upon registration.

If you are registering on behalf of someone else, the link to access the webinar will go to the email address provided at the point of registration.

Those registering on the day of the webinar will receive an access link via email upon successful payment.


We use Zoom to conduct webinars which works on most devices. You may participate in the webinar on a mobile device via the Zoom App or by dialing in. If you require the dial in information, please contact Maura Schatz at [email protected].

Test your device:


Webinar recordings are sent via email as soon as we are able to process and verify the quality of the recording. This usually occurs within 3 business days of a webinar broadcast.

If multiple people at your organization wish to participate from separate devices, each will be required to purchase access.